Bio Impedance Electrical Analysis to Predict Outcome After Cardiac Surgery
- Conditions
- Post Operative Care After Cardiac Surgery With Cardio Pulmonary Bypass
- Interventions
- Diagnostic Test: Bioelectrical impedance analysis
- Registration Number
- NCT05229159
- Lead Sponsor
- Hospices Civils de Lyon
- Brief Summary
Phase angle determined by bioelectrical impedance analysis is a strong prognostic factor in several medical areas as clinical nutrition, nephrology, infectious disease, oncology. Inflammation, frailty status and fluid overload can lead to a phase angle decreased. Some studies support its use for risk stratification in intensive care unit and other in preoperative for cardiac surgery. The investigators would like to evaluate its relevance for risk stratification at intensive care unit admission in the context of postoperative cardiac surgery with cardiopulmonary bypass.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 220
- Age higher than 18
- Cardiac surgery with cardiopulmonary bypass
- Bioelectrical impedance analysis the day of the admission in intensive care unit
- Left ventricular assist device
- Limitations des th茅rapeutiques actives en place pour le patient
- Patient opposition to the use of his health data
- Invalid bioelectrical impedance analysis
- Advanced directives to withhold or withdraw life-sustaining treatment
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description BiPOCS group Bioelectrical impedance analysis All patients of our centers admitted for postoperative care after cardiac surgery with cardiopulmonary bypass and receiving a bioelectrical impedance analysis at the admission.
- Primary Outcome Measures
Name Time Method Area under the receiver operating characteristic curve to predict a composite criterion including in-hospital mortality or prolonged hospital length of stay. at 6 months after the cardiac surgery The phase angle's area under the receptor operative curve to predict a composite criteria evaluated at hospital discharge and combining:
* In hospital mortality
* Prolonged hospital length of stay, defined by an in hospital length of stay greater than the 75th percentile of length of stay in the study population"
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
H么pital cardiologique Louis Pradel Groupe Hospitalier Est
馃嚝馃嚪Bron, Rh么ne, France